Clinical Trials Directory

Trials / Unknown

UnknownNCT00162409

Relationship Between Folic Acid and Warfarin Metabolism and Effect

The Effect of Folic Acid Concentration and Folic Acid Supplementation on Warfarin Pharmacokinetic and Warfarin Dose Requirement at Steady State.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Folic acid supplementation has been shown previously to be associated with enhanced formation of p-HPPH from phenytoin, a metabolic pathway which is predominantly mediated through the activity of CYP2C9. The metabolism of S warfarin, the more active enantiomer of warfarin, is also mediated predominantly through the activity of CYP2C9. The purpose of the present study was to examine the relationship between folic acid concentration and warfarin pharmacokinetic as well as warfarin dose requirement among patients treated by warfarin. In addition the effect of folic acid supplementation (5 mg/d) for 3 weeks on warfarin pharmacokinetic and warfarin dose requirement will be evaluated in the second part of the study.

Conditions

Interventions

TypeNameDescription
DRUGFolic acid

Timeline

Start date
2001-08-01
First posted
2005-09-13
Last updated
2008-10-29

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00162409. Inclusion in this directory is not an endorsement.

Relationship Between Folic Acid and Warfarin Metabolism and Effect (NCT00162409) · Clinical Trials Directory